Expression of pulmonary arterial elastin in rats with hypoxic pulmonary hypertension using H2S

References

• Shi Y, Du J, Guo Z, et al. Interaction between endogenous nitric oxide and carbon monoxide in the pathogenesis of hypoxic pulmonary hypertension. Chin Sci Bull. 2003;48(1):86–90.
   Google Scholar
• Liu P, Yan S, Chen M, et al. Effects of baicalin on collagen Ι and collagen ΙΙΙ expression in pulmonary arteries of rats with hypoxic pulmonary hypertension. Int J Mol Med. 2015;35(4):901–908.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wang J, Tian HUA, et al. Increased SUMO-1 expression in response to hypoxia: Interaction with HIF-1α in hypoxic pulmonary hypertension. Int J Mol Med. 2015;36(1):271–281.
   PubMed Web of Science ®Google Scholar
• Li Y, Shi B, Huang L, et al. Suppression of the expression of hypoxia-inducible factor-1α by RNA interference alleviates hypoxia-induced pulmonary hypertension in adult rats. Int J Mol Med. 2016;38(6):1786–1794.
   PubMed Web of Science ®Google Scholar
• Liu M, Liu Q, Zhang Y, et al. Aqp-1 gene knockout attenuates hypoxic pulmonary hypertension of mice. ATVB. 2019;39(1):48–62.
   Google Scholar
• Ahmed MS, Giesinger RE, Ibrahim M, et al. Clinical and echocardiography predictors of response to inhaled nitric oxide in hypoxic preterm neonates. J Paediatr Child Health. 2019; 55(7):753–761.
   PubMed Web of Science ®Google Scholar
• Pi W-F, Xue-Jun G, Su L-P, et al. Troglitazone upregulates PTEN expression and induces the apoptosis of pulmonary artery smooth muscle cells under hypoxic conditions. Int J Mol Med. 2013;32(5):1101–1109.
   PubMed Web of Science ®Google Scholar
• Kojima H, Tokunou T, Takahara Y, et al. Hypoxia‐inducible factor‐1 α deletion in myeloid lineage attenuates hypoxia‐induced pulmonary hypertension. Physiol Rep. 2019;7(7):e14025.
   PubMed Web of Science ®Google Scholar
• Zheng M, Zhao M, Tang L, et al. Ginsenoside Rg1 attenuates hypoxia and hypercapnia-induced vasoconstriction in isolated rat pulmonary arterial rings by reducing the expression of p38. J Thorac Dis. 2016;8(7):1513–1523.
   PubMed Web of Science ®Google Scholar
• Yong-Liang J, Dai A-G, Li Q-F, et al. Transforming growth factor-β1 induces transdifferentiation of fibroblasts into myofibroblasts in hypoxic pulmonary vascular remodeling. Acta Biochim Biophys Sinica. 2006;38(1):29–36.
   PubMed Web of Science ®Google Scholar
• Saw CL, Rakshasbhuvankar A, Rao S, et al. Current practice of therapeutic hypothermia for mild hypoxic ischemic encephalopathy. J Child Neurol. 2019;34(7):402–409.
   PubMed Web of Science ®Google Scholar
• Boucherat O, Bonnet S. The ROS controversy in hypoxic pulmonary hypertension revisited. Eur Respir J. 2018;51(3). DOI:10.1183/13993003.00276-2018
   PubMed Web of Science ®Google Scholar
• Amer R, Elsayed YN, Graham MR, et al. Effect of vasopressin on a porcine model of persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 2019;54(3):319–332.
   PubMed Web of Science ®Google Scholar
• Wang F, Xu X, Tang W, et al. Rab6A GTPase contributes to phenotypic modulation in pulmonary artery smooth muscle cells under hypoxia. J Cell Biochem. 2019;120(5):7858–7867.
   Web of Science ®Google Scholar
• Bussotti M, Marchese G. High altitude pulmonary hypertension. CHDDT. 2018;18(3):187–198.
   Google Scholar
• Luo Q, Wang X, Liu R, et al. alpha1A‐adrenoceptor is involved in norepinephrine‐induced proliferation of pulmonary artery smooth muscle cells via CaMKII signaling. J Cell Biochem. 2019;120(6):9345–9355.
   PubMed Web of Science ®Google Scholar
• Yum SK, Seo YM, Kwun Y, et al. Therapeutic hypothermia in infants with hypoxic–ischemic encephalopathy and reversible persistent pulmonary hypertension: short-term hospital outcomes. J Maternal-Fetal Neonatal Med. 2018;31(23):3108–3114.
   PubMed Web of Science ®Google Scholar
• Hung MW, Yeung HM, Lau CF, et al. Melatonin attenuates pulmonary hypertension in chronically hypoxic rats. J Turbul. 2017;18(6). DOI:10.3390/ijms18061125
   Google Scholar
• Özgür Yurttaş N, Eşkazan AE. Dasatinib‐induced pulmonary arterial hypertension. Br J Clin Pharmacol. 2018;84(5):835–845.
   PubMed Web of Science ®Google Scholar
• Balmain BN ,Seale H ,Harris J, et al. Relating exercise-induced desaturation and gas-exchange in pulmonary artery hypertension. Respir Physiol Neurobiol. 2019;259:58–62.
   PubMed Web of Science ®Google Scholar
• Stembridge M, Ainslie PN, Boulet LM, et al. The independent effects of hypovolaemia and pulmonary vasoconstriction on ventricular function and exercise capacity during acclimatisation to 3800 m. J Physiol. 2019;597(4):1059–1072.
   PubMed Web of Science ®Google Scholar
• Zhou S, Sun L, Cao C, et al. Hypoxia‐induced microRNA‐26b inhibition contributes to hypoxic pulmonary hypertension via CTGF. J Cell Biochem. 2018;119(2):1942–1952.
   PubMed Web of Science ®Google Scholar
• Pool C, Jin M, Chen YB, et al. Hypoxic‐induction of arginase II requires EGF‐mediated EGFR activation in human pulmonary microvascular endothelial cells. Physiol Rep. 2018;6(10):e13693.
   PubMed Web of Science ®Google Scholar
• Li J, Liang X, Zhou Y, et al. Role of dynorphin in hypoxic pulmonary hypertension. Eur J Pharmacol. 2016;791:78–84.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Togari H, Potenziano JL, et al. Efficacy of inhaled nitric oxide in neonates with hypoxic respiratory failure and pulmonary hypertension: the Japanese experience. J Perinat Med. 2018;46(6):657–663.
   PubMed Web of Science ®Google Scholar
• Mu YP ,Huang QH ,Zhu JL, et al. Magnesium attenuates endothelin‐1‐induced vasoreactivity and enhances vasodilatation in mouse pulmonary arteries: modulation by chronic hypoxic pulmonary hypertension. Exp Physiol. 2018;103(4):604–616.
   PubMed Web of Science ®Google Scholar
• Kumar R, Mickael C, Kassa B, et al. Dysregulated metabolism in interstitial macrophages may contribute to thrombospondin-1 mediated hypoxic pulmonary hypertension. J Invest Med. 2018;66(4):875.
   Web of Science ®Google Scholar
• Umar S, Cunningham CM, Itoh Y, et al. The Y chromosome plays a protective role in experimental hypoxic pulmonary hypertension. Am J Respir Crit Care Med. 2018;197(7):952–955.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tian X, Zhang S, et al. Quaternary ammonium salt of U50,488H elicits protective effects against hypoxic pulmonary hypertension. Eur J Pharmacol. 2018;832:129–137.
   PubMed Web of Science ®Google Scholar
• Garcia-Morales LJ, Chen N-Y, Weng T, et al. Altered hypoxic-adenosine axis and metabolism in group III pulmonary hypertension. Am J Respir Cell Mol Biol. 2016;54(4):574–583.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhu T, Wu W, et al. LOX-1 mediated phenotypic switching of pulmonary arterial smooth muscle cells contributes to hypoxic pulmonary hypertension. Eur J Pharmacol. 2018;818:84–95.
   PubMed Web of Science ®Google Scholar
• Lichtblau M, Schneider SR, Bader PR, et al. Acute hemodynamic changes by breathing hypoxic and hyperoxic gas mixtures in pulmonary arterial and chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2018;270:262–267.
   PubMed Web of Science ®Google Scholar
• Reyes RV, Díaz M, Ebensperger G, et al. The role of nitric oxide in the cardiopulmonary response to hypoxia in highland and lowland newborn llamas. J Physiol. 2018;596(23):5907–5923.
   PubMed Web of Science ®Google Scholar
• Rowan SC, McLoughlin P. Hypoxic pulmonary hypertension: the paradigm is changing. Exp Physiol. 2014;99(6):837–838.
   PubMed Web of Science ®Google Scholar
• Rowan SC, Keane MP, Gaine S, et al. Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways. Lancet Respir Med. 2016;4(3):225–236.
   PubMed Web of Science ®Google Scholar